Search Legislation

Genetically Modified Organisms (Contained Use) (Amendment) Regulations (Northern Ireland) 1996

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As made)

More Resources

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Explanatory Note

(This note is not part of the Regulations.)

These Regulations amend the Genetically Modified Organisms (Contained Use) Regulations (Northern Ireland) 1994 (“the principal Regulations”) in the following ways—

Paragraph 2(a) of Schedule 1

1.  Council Directive 90/219/EEC (O.J. No. L117, 8.5.90, p. 1), on the contained use of genetically modified micro-organisms, implemented by the principal Regulations, applies to the States of the European Economic Area by virtue of the Agreement on the European Economic Area. A definition of “member State”, which includes those States, is, therefore, inserted into regulation 2(1) of the principal Regulations. Definitions of “the European Economic Area” and “the Agreement” are also inserted into that regulation.

2.  The definition of “organism” in regulation 2(1) of the principal Regulations is amended to exclude humans and human embryos, which are outside the scope of the above Directive.

Paragraphs 2(b), 5 and 6 of Schedule 1; Schedule 2

3.  Regulation 2(2) of, and Schedule 2 to, the principal Regulations are replaced, to implement the new classification criteria for micro-organisms contained in Commission Directive 94/51/EC (O.J. No. L297, 18.11.94, p. 29), which adapts to technical progress Council Directive 90/219/EEC. There are minor consequential amendments to regulation 9 of, and paragraph 3(e) of Schedule 1 to, the principal Regulations.

Paragraph 3 of Schedule 1

4.  By Article 5 of Council Directive 90/219/EEC, genetically modified micro-organisms marketed in accordance with other Community legislation providing equivalent risk assessment to that required under the said Directive are excluded from the scope of that Directive as regards storage, transport, destruction and disposal. The exemptions contained in regulation 6(2)(a) of the principal Regulations are extended to exclude from the prohibitions in regulation 6(1) certain medicinal products marketed in accordance with Council Regulation (EEC) No. 2309/93 (O.J. No. L214, 24.8.93, p. 1).

Paragraph 4 of Schedule 1

5.  Regulation 8(2) of the principal Regulations is amended to provide that a separate notification is not required where a consent for Group II micro-organisms has already been granted and it is intended to use the premises for activities involving Group I organisms, or where simultaneous notification is being given for activities involving Group I and II organisms at the same premises.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources